Deciphera Pharmaceuticals Llc Stock Market Value
| DCPH Stock | USD 25.38 0.01 0.04% |
| Symbol | Deciphera |
Deciphera Pharmaceuticals Price To Book Ratio
Is Deciphera Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Deciphera Pharmaceuticals. If investors know Deciphera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Deciphera Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.29) | Revenue Per Share 1.92 | Quarterly Revenue Growth 0.329 | Return On Assets (0.28) | Return On Equity (0.56) |
The market value of Deciphera Pharmaceuticals is measured differently than its book value, which is the value of Deciphera that is recorded on the company's balance sheet. Investors also form their own opinion of Deciphera Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Deciphera Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Deciphera Pharmaceuticals' market value can be influenced by many factors that don't directly affect Deciphera Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Deciphera Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Deciphera Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Deciphera Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Deciphera Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Deciphera Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Deciphera Pharmaceuticals.
| 04/08/2024 |
| 05/08/2024 |
If you would invest 0.00 in Deciphera Pharmaceuticals on April 8, 2024 and sell it all today you would earn a total of 0.00 from holding Deciphera Pharmaceuticals LLC or generate 0.0% return on investment in Deciphera Pharmaceuticals over 30 days. Deciphera Pharmaceuticals is related to or competes with Eagle Pharmaceuticals, ANI Pharmaceuticals, Phibro Animal, Prestige Brand, Evotec SE, Supernus Pharmaceuticals, and Collegium Pharmaceutical. Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by ... More
Deciphera Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Deciphera Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Deciphera Pharmaceuticals LLC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.57 | |||
| Information Ratio | 0.1179 | |||
| Maximum Drawdown | 72.6 | |||
| Value At Risk | (4.32) | |||
| Potential Upside | 5.21 |
Deciphera Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Deciphera Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Deciphera Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Deciphera Pharmaceuticals historical prices to predict the future Deciphera Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.088 | |||
| Jensen Alpha | 1.42 | |||
| Total Risk Alpha | 0.1912 | |||
| Sortino Ratio | 0.4287 | |||
| Treynor Ratio | (0.30) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Deciphera Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Deciphera Pharmaceuticals Backtested Returns
Deciphera Pharmaceuticals is slightly risky given 3 months investment horizon. Deciphera Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.13, which denotes the company had a 0.13% return per unit of standard deviation over the last 3 months. We were able to interpolate data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.27% are justified by taking the suggested risk. Use Deciphera Pharmaceuticals Downside Deviation of 2.57, mean deviation of 3.44, and Semi Deviation of 1.85 to evaluate company specific risk that cannot be diversified away. Deciphera Pharmaceuticals holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -3.85, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Deciphera Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Deciphera Pharmaceuticals is expected to outperform it. Use Deciphera Pharmaceuticals potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to analyze future returns on Deciphera Pharmaceuticals.
Auto-correlation | -0.82 |
Excellent reverse predictability
Deciphera Pharmaceuticals LLC has excellent reverse predictability. Overlapping area represents the amount of predictability between Deciphera Pharmaceuticals time series from 8th of April 2024 to 23rd of April 2024 and 23rd of April 2024 to 8th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Deciphera Pharmaceuticals price movement. The serial correlation of -0.82 indicates that around 82.0% of current Deciphera Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.82 | |
| Spearman Rank Test | -0.81 | |
| Residual Average | 0.0 | |
| Price Variance | 27.09 |
Deciphera Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Deciphera Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Deciphera Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Deciphera Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Deciphera Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Deciphera Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Deciphera Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Deciphera Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Deciphera Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Deciphera Pharmaceuticals Lagged Returns
When evaluating Deciphera Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Deciphera Pharmaceuticals stock have on its future price. Deciphera Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Deciphera Pharmaceuticals autocorrelation shows the relationship between Deciphera Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Deciphera Pharmaceuticals LLC.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Deciphera Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Deciphera Pharmaceuticals' short interest history, or implied volatility extrapolated from Deciphera Pharmaceuticals options trading.
Pair Trading with Deciphera Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Deciphera Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deciphera Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Deciphera Stock
| 0.83 | ELYM | Eliem Therapeutics Trending | PairCorr |
Moving against Deciphera Stock
| 0.48 | BMY | Bristol Myers Squibb | PairCorr |
| 0.41 | GILD | Gilead Sciences Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Deciphera Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Deciphera Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Deciphera Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Deciphera Pharmaceuticals LLC to buy it.
The correlation of Deciphera Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Deciphera Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Deciphera Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Deciphera Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Deciphera Pharmaceuticals Correlation, Deciphera Pharmaceuticals Volatility and Deciphera Pharmaceuticals Alpha and Beta module to complement your research on Deciphera Pharmaceuticals. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Deciphera Stock analysis
When running Deciphera Pharmaceuticals' price analysis, check to measure Deciphera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Deciphera Pharmaceuticals is operating at the current time. Most of Deciphera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Deciphera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Deciphera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Deciphera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Deciphera Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.